Drug Type Therapeutic vaccine |
Synonyms IPT 001, IPT001 |
Target |
Action inhibitors |
Mechanism ERV env inhibitors(Envelope ERV derived genes inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Metabolic dysfunction-associated steatotic liver disease | Preclinical | Denmark | 01 Jul 2025 | |
| Non-Small Cell Lung Cancer | Preclinical | Denmark | 01 Jul 2025 | |
| Prediabetic State | Preclinical | Denmark | 01 Jul 2025 | |
| Pancreatic Cancer | Preclinical | Denmark | 01 Apr 2025 | |
| Prostatic Cancer | Preclinical | Denmark | 01 Apr 2025 | |
| Diabetes Mellitus, Type 2 | Discovery | Denmark | 01 Apr 2025 |





